Apparent involvement of a multidrug transporter in the fluoroquinolone resistance of Streptococcus pneumoniae

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 6, 1997, Pages 1396-1398

  Baranova, Natalya N ^a   Neyfakh, Alexander A ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALOID; AMPICILLIN; CHLORAMPHENICOL; CIPROFLOXACIN; ERYTHROMYCIN; ETHIDIUM BROMIDE; GLYCOPROTEIN P; NORFLOXACIN; NOVOBIOCIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RESERPINE; RIFAMPICIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GROWTH; CONTROLLED STUDY; CROSS RESISTANCE; DRUG INHIBITION; DRUG POTENTIATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE;

EID: 0030918973     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.6.1396     Document Type: Article

References (17)

1. Ahmed, M., C. M. Borsch, A. A. Neyfakh, and S. Schuldiner. 1993. Mutants of the Bacillus subtilis multidrug transporter Bmr with altered sensitivity to the antihypertensive alkaloid reserpine. J. Biol. Chem. 268:11086-11089.
2. Ahmed, M., L. Lyass, P. N. Markham, S. S. Taylor, N. Vázquez-Laslop, and A. A. Neyfakh. 1995. Two highly similar multidrug transporters of Bacillus subtilis whose expression is differentially regulated. J. Bacteriol. 177:3904-3910.
3. Bolhuis, H., G. Poelarends, H. W. van Veen, B. Poolman, A. J. M. Driessen, and W. N. Konings. 1995. The lactococcal lmrP gene encodes a proton motive force-dependent drug transporter. J. Biol. Chem. 270:26092-26098.
4. Davis, R., A. Markham, and J. A. Balfour. 1996. Ciprofloxacin. An updated review on its pharmacology, therapeutic efficacy and tolerability. Drugs 51: 1019-1074.
5. Janoir, C., V. Zeller, M.-D. Kitzis, N. J. Moreau, and L. Gutmann. 1996. High-level fluoroquinolone resistance in Streptococcus pneumoniae requires mutations in parC and gyrA. Antimicrob. Agents Chemother. 40:2760-2764.
6. Lambert, B., and J. B. LePecq. 1984. Effect of mutation, electric membrane potential, and metabolic inhibitors on the accessibility of nucleic acids to ethidium bromide in Escherichia coli cells. Biochemistry 23:166-176.
7. Morrison, D. A., S. A. Lacks, W. R. Guild, and J. M. Hageman. 1983. Isolation and characterization of three new classes of transformation-deficient mutants of Streptococcus pneumoniae that are defective in DNA transport and genetic recombination. J. Bacteriol. 156:281-290.
8. Neyfakh, A. A., V. E. Bidnenko, and L. B. Chen. 1991. Efflux-mediated multidrug resistance in Bacillus subtilis: similarities and dissimilarities with the mammalian system. Proc. Natl. Acad. Sci. USA 88:4781-4785.
9. Neyfakh, A. A., C. M. Borsch, and G. W. Kaatz. 1993. Fluoroquinolone resistance protein NorA of Staphylococcus aureus is a multidrug efflux transporter. Antimicrob. Agents Chemother. 37:128-129.
10. Ohki, R., and M. Murata. 1997. bmr3, a third multidrug transporter gene of Bacillus subtilis. J. Bacteriol. 179:1423-1427.
11. Pan, X.-S., J. Ambler, S. Mehtar, and L. M. Fisher. 1996. Involvement of topoisomerase IV and DNA gyrase as ciprofloxacin targets in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 40:2321-2326.
12. Paulsen, I. T., M. H. Brown, and R. A. Skurray. 1996. Proton-dependent multidrug efflux systems. Microbiol. Rev. 60:575-608.
13. Porter, R. D., and W. R. Guild. 1976. Characterization of some pneumococcal bacteriophages. J. Virol. 19:659-667.
14. Takiff, H. E., M. Cinuino, M. C. Musso, T. Weisbrod, R. Martinez, L. Salazar, B. R. Bloom, and W. R. Jacobs. 1996. Efflux pump of the proton antiporter family confers low level fluoroquinolone resistance in Mycobacterium smegmatis. Proc. Natl. Acad. Sci. USA 93:362-366.
15. Tankovic, J., B. Perichon, J. Duval, and P. Courvalin. 1996. Contribution of mutations in gyrA and parC genes to fluoroquinolone resistance of mutants of Streptococcus pneumoniae obtained in vivo and in vitro. Antimicrob. Agents Chemother. 40:2505-2510.
16. van Veen, H. W., K. Venema, H. Bolhuis, I. Oussenko, J. Kok, B. Poolman, A. J. M. Driessen, and W. N. Konings. 1996. Multidrug resistance mediated by a bacterial homolog of the human multidrug transporter MDR1. Proc. Natl. Acad. Sci. USA 93:10668-10672.
17. Yoshida, H., M. Bogaki, S. Nakamura, K. Ubukata, and M. Konno. 1990. Nucleotide sequence and characterization of the Staphylococcus aureus norA gene, which confers resistance to quinolones. J. Bacteriol. 172:6942-6949.